126 related articles for article (PubMed ID: 7838330)
1. Prognostic implications of p53 overexpression in supratentorial astrocytic tumors.
Chozick BS; Pezzullo JC; Epstein MH; Finch PW
Neurosurgery; 1994 Nov; 35(5):831-7; discussion 837-8. PubMed ID: 7838330
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining.
Hwang SL; Hong YR; Chai CY; Lin HJ; Howng SL
Kaohsiung J Med Sci; 1998 Oct; 14(10):607-15. PubMed ID: 9819502
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53 immunoreactivity in adult patients with supratentorial fibrillary astrocytic neoplasms.
Montine TJ; Bruner JM; Vandersteenhoven JJ; Dodge RK; Burger PC
Diagn Mol Pathol; 1994 Dec; 3(4):240-5. PubMed ID: 7866633
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
[TBL] [Abstract][Full Text] [Related]
8. Genetic sub-types of human malignant astrocytoma correlate with survival.
Leenstra S; Oskam NT; Bijleveld EH; Bosch DA; Troost D; Hulsebos TJ
Int J Cancer; 1998 Apr; 79(2):159-65. PubMed ID: 9583731
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms.
Montine TJ; Vandersteenhoven JJ; Aguzzi A; Boyko OB; Dodge RK; Kerns BJ; Burger PC
Neurosurgery; 1994 Apr; 34(4):674-8; discussion 678-9. PubMed ID: 8008166
[TBL] [Abstract][Full Text] [Related]
10. Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.
Lai DM; Lin SM; Tu YK; Kao MC; Hung CC
J Formos Med Assoc; 1993 Mar; 92(3):220-6. PubMed ID: 8102273
[TBL] [Abstract][Full Text] [Related]
11. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
Okamoto Y; Di Patre PL; Burkhard C; Horstmann S; Jourde B; Fahey M; Schüler D; Probst-Hensch NM; Yasargil MG; Yonekawa Y; Lütolf UM; Kleihues P; Ohgaki H
Acta Neuropathol; 2004 Jul; 108(1):49-56. PubMed ID: 15118874
[TBL] [Abstract][Full Text] [Related]
12. Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study.
Kurimoto M; Hayashi N; Kamiyama H; Nagai S; Shibata T; Asahi T; Matsumura N; Hirashima Y; Endo S
Minim Invasive Neurosurg; 2004 Oct; 47(5):278-83. PubMed ID: 15578340
[TBL] [Abstract][Full Text] [Related]
13. Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma.
Danks RA; Chopra G; Gonzales MF; Orian JM; Kaye AH
Neurosurgery; 1995 Aug; 37(2):246-54. PubMed ID: 7477776
[TBL] [Abstract][Full Text] [Related]
14. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
15. Malignant supratentorial astrocytomas of late childhood. Our experience with 25 cases.
Raco A; Bristot R; Salvati M; Delfini R
Childs Nerv Syst; 1997 Jun; 13(6):341-4. PubMed ID: 9272287
[TBL] [Abstract][Full Text] [Related]
16. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis.
Jungk C; Scherer M; Mock A; Capper D; Radbruch A; von Deimling A; Bendszus M; Herold-Mende C; Unterberg A
J Neurooncol; 2016 Sep; 129(2):319-28. PubMed ID: 27344556
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.
Kraus JA; Glesmann N; Beck M; Krex D; Klockgether T; Schackert G; Schlegel U
J Neurooncol; 2000 Jun; 48(2):89-94. PubMed ID: 11083071
[TBL] [Abstract][Full Text] [Related]
19. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas.
Piepmeier J; Christopher S; Spencer D; Byrne T; Kim J; Knisel JP; Lacy J; Tsukerman L; Makuch R
Neurosurgery; 1996 May; 38(5):872-8; discussion 878-9. PubMed ID: 8727811
[TBL] [Abstract][Full Text] [Related]
20. p53 protein expression in grade II astrocytomas: immunohistochemical study of 100 cases with long-term follow-up.
Vital A; Loiseau H; Kantor G; Daucourt V; Chene G; Cohadon F; Rougier A; Rivel J; Vital C
Pathol Res Pract; 1998; 194(12):831-6. PubMed ID: 9894248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
